MX2023007810A - Compuestos de complejo de hierro para uso terapeutico. - Google Patents

Compuestos de complejo de hierro para uso terapeutico.

Info

Publication number
MX2023007810A
MX2023007810A MX2023007810A MX2023007810A MX2023007810A MX 2023007810 A MX2023007810 A MX 2023007810A MX 2023007810 A MX2023007810 A MX 2023007810A MX 2023007810 A MX2023007810 A MX 2023007810A MX 2023007810 A MX2023007810 A MX 2023007810A
Authority
MX
Mexico
Prior art keywords
complex compounds
iron complex
therapeutic use
iron
arsenic
Prior art date
Application number
MX2023007810A
Other languages
English (en)
Inventor
Tobias S Christensen
Hans B Andreasen
Original Assignee
Pharmacosmos Holding As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacosmos Holding As filed Critical Pharmacosmos Holding As
Publication of MX2023007810A publication Critical patent/MX2023007810A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • C07F15/02—Iron compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

La presente invención se refiere a compuestos de complejo de hierro para uso terapéutico que son bajos en arsénico, cromo, plomo, cadmio, mercurio y/o aluminio, a composiciones de los mismos y a procesos de preparación de dichos compuestos de complejo de hierro.
MX2023007810A 2017-09-11 2020-03-05 Compuestos de complejo de hierro para uso terapeutico. MX2023007810A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP17190302 2017-09-11

Publications (1)

Publication Number Publication Date
MX2023007810A true MX2023007810A (es) 2023-07-11

Family

ID=59923237

Family Applications (3)

Application Number Title Priority Date Filing Date
MX2020002527A MX2020002527A (es) 2017-09-11 2018-09-10 Compuestos de complejo de hierro para uso terapeutico.
MX2023007810A MX2023007810A (es) 2017-09-11 2020-03-05 Compuestos de complejo de hierro para uso terapeutico.
MX2023007809A MX2023007809A (es) 2017-09-11 2020-03-05 Compuestos de complejo de hierro para uso terapeutico.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2020002527A MX2020002527A (es) 2017-09-11 2018-09-10 Compuestos de complejo de hierro para uso terapeutico.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2023007809A MX2023007809A (es) 2017-09-11 2020-03-05 Compuestos de complejo de hierro para uso terapeutico.

Country Status (12)

Country Link
US (3) US11111261B2 (es)
EP (1) EP3681539A1 (es)
JP (2) JP7426927B2 (es)
KR (1) KR20200044030A (es)
CN (1) CN111050802A (es)
AU (2) AU2018328052C1 (es)
BR (1) BR112020004357A2 (es)
MA (1) MA50229A (es)
MX (3) MX2020002527A (es)
SG (1) SG11202001594TA (es)
WO (1) WO2019048674A1 (es)
ZA (1) ZA202001283B (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111050802A (zh) * 2017-09-11 2020-04-21 法码科思莫斯控股有限公司 用于治疗用途的铁络合物化合物
SG11202107050RA (en) 2019-01-10 2021-07-29 Pharmacosmos Holding As Treating iron deficiency in subjects at risk of cardiovascular adverse events and iron for the management of atrial fibrillation
JP7320611B2 (ja) 2019-02-28 2023-08-03 レニバス・セラピューティクス・インコーポレイテッド 新規鉄組成物及びその製造方法と使用方法
EA202191858A1 (ru) 2019-06-12 2021-11-12 Фармакосмос Холдинг А/С Лечение дефицита железа у субъектов с риском нежелательных явлений со стороны сердечно-сосудистой системы и железо для лечения фибрилляции предсердий
KR20240041957A (ko) 2021-08-03 2024-04-01 파르마코스모스 홀딩 에이/에스 반려동물의 철 결핍증 치료방법에서 피하 사용을 위한 철 착화합물
CN117379387A (zh) * 2022-01-13 2024-01-12 上海医药集团青岛国风药业股份有限公司 一种多糖铁胶囊内容组合物及方法
CN115177625A (zh) * 2022-06-28 2022-10-14 金陵药业股份有限公司 一种羧基麦芽糖铁药用组合物及其制备方法
KR102623739B1 (ko) * 2022-07-28 2024-01-11 주식회사 페라메드 시트르산과 철을 포함하는 착화합물 및 그를 포함하는 식품 조성물

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR607134A (fr) 1924-12-03 1926-06-26 Basf Ag Procédé pour la production du fer carbonyle
FR654013A (fr) * 1928-05-09 1929-03-30 Procédé de réglage de la carburation dans les moteurs à explosions et dispositifen permettant la réalisation
US2096855A (en) * 1934-07-27 1937-10-26 Innis Speiden & Co Manufacture of ferric chloride
US3639588A (en) 1966-10-22 1972-02-01 Fisons Pharmaceuticals Ltd Pharmaceutical compositions containing ferric hydroxide complexed with dextran or dextrin heptonic acids
US3906077A (en) 1974-02-15 1975-09-16 Kerr Mc Gee Chem Corp Purification of ferric chloride
US4056386A (en) 1977-04-19 1977-11-01 The United States Of America As Represented By The Secretary Of The Navy Method for decomposing iron pentacarbonyl
WO1999043408A1 (en) 1998-02-25 1999-09-02 Wadhawan Satish C Solvent extraction of ferric chloride
DK172860B1 (da) 1998-03-25 1999-08-16 Pharmacosmos Holding As Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman
DK173138B1 (da) 1998-11-20 2000-02-07 Pharmacosmos Holding As Fremgangsmåde til fremstilling af en jerndextranforbindelse, jerndextranforbindelse fremstillet efter fremgangsmåden, farma
US7871597B2 (en) 1999-04-09 2011-01-18 Amag Pharmaceuticals, Inc. Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents
DE10249552A1 (de) 2002-10-23 2004-05-13 Vifor (International) Ag Wasserlösliche Eisen-Kohlenhydrat-Komplexe, deren Herstellung und diese enthaltende Arzneimittel
US20060134227A1 (en) 2004-12-22 2006-06-22 Bortz Jonathan D Compositions including iron
ITMO20050056A1 (it) * 2005-03-15 2006-09-16 Biofer Spa Processo per la preparazione di complessi del ferro trivalente con zuccheri mono-, di- e polisaccaridi.
GB0702270D0 (en) * 2007-02-06 2007-03-14 Medical Res Council Ligand modified poly oxo-hydroxy metal ion materials, their uses and processes for their preparation
MX2009008281A (es) 2007-02-06 2009-08-25 Medical Res Council Materiales de ion metalico de poli-oxo-hidroxi modificados con ligando, sus usos y procesos para su preparacion.
PT2411053T (pt) * 2009-03-25 2017-02-15 Pharmacosmos Holding As Composto oligossacarídico de ferro estável
CN102065406B (zh) 2009-11-12 2014-04-09 中兴通讯股份有限公司 一种本地呼叫本地交换的实现方法
EP3212182B1 (en) 2014-10-27 2019-06-26 Pharmacosmos Holding A/S Treatment or prevention of anaemia in pregnant non-human mammals and offspring
EP2913054A1 (en) 2015-03-19 2015-09-02 Pharmacosmos Holding A/s Iron carbohydrate complex for treatment of restless leg syndrome (rls)
WO2016181195A1 (en) * 2015-05-08 2016-11-17 Suven Life Sciences Limited Improved process for water soluble iron carbohydrate complexes
CN116889576A (zh) 2015-06-22 2023-10-17 法码科思莫斯控股有限公司 用于治疗胎儿或婴儿铁缺乏的铁碳水化合物复合物
CN105095365A (zh) 2015-06-26 2015-11-25 北京奇虎科技有限公司 一种信息流数据的处理方法和装置
US20190282613A1 (en) * 2016-05-20 2019-09-19 Obshestvo S Ogranichennoj Otvetstvennostju "Vik- Zdorove Zhivotnyh" Injection composition comprising an iron dextran complex and vitamins for preventing and treating anemia
CN111050802A (zh) * 2017-09-11 2020-04-21 法码科思莫斯控股有限公司 用于治疗用途的铁络合物化合物

Also Published As

Publication number Publication date
US20220041640A1 (en) 2022-02-10
JP7426927B2 (ja) 2024-02-02
US20240279262A1 (en) 2024-08-22
WO2019048674A1 (en) 2019-03-14
KR20200044030A (ko) 2020-04-28
MA50229A (fr) 2020-07-22
MX2020002527A (es) 2020-10-12
AU2024203596A1 (en) 2024-06-20
US11111261B2 (en) 2021-09-07
SG11202001594TA (en) 2020-03-30
BR112020004357A2 (pt) 2020-09-08
EP3681539A1 (en) 2020-07-22
ZA202001283B (en) 2022-11-30
AU2018328052A1 (en) 2020-03-26
CN111050802A (zh) 2020-04-21
AU2018328052B2 (en) 2024-02-29
AU2018328052C1 (en) 2024-08-08
RU2020113257A3 (es) 2022-04-25
JP2020533300A (ja) 2020-11-19
RU2020113257A (ru) 2021-10-13
JP2023164477A (ja) 2023-11-10
MX2023007809A (es) 2023-07-11
US20190177353A1 (en) 2019-06-13

Similar Documents

Publication Publication Date Title
MX2023007810A (es) Compuestos de complejo de hierro para uso terapeutico.
PH12019502875A1 (en) Antibody molecules to cd73 and uses thereof
MX2020009649A (es) Anticuerpos monoclonales contra bcma.
MX2023010042A (es) Polinucleotidos moduladores.
ZA201906832B (en) Novel psma-binding agents and uses thereof
PH12018502225A1 (en) Anti-il-33 antibodies, compositions, methods and uses thereof
MX2019003623A (es) Composiciones y metodos para el tratamiento de afecciones oftalmicas.
MX2018006240A (es) Composiciones que comprenden cepas bacterianas.
PH12016501763A1 (en) Multispecific antibodies
MX2019007021A (es) Anticuerpos il-11ra.
NZ738008A (en) Tigit-binding agents and uses thereof
MA42471B1 (fr) Compositions comprenant des souches bactériennes
MX2022015755A (es) Profarmacos de hormona paratiroidea (pth).
NZ737843A (en) Tau-binding antibodies
NZ766128A (en) Antibodies binding axl
MY193677A (en) Tau-binding antibodies
MX2018000715A (es) Metodos para tratar cancer usando apilimod.
MX2016009590A (es) Composiciones de apilimod y métodos para usar las mismas.
MX2017008390A (es) Uretanos funcionalizados con alcoxisilano y funcionalizados con alofanato.
GB2568181A (en) Wheat
MX2020003219A (es) Anticuerpos que tienen especificidad para btn2 y usos de los mismos.
PH12021550102A1 (en) Cardiosafe antidiabetic therapy
MX2017010883A (es) Composicion para el tratamiento de la infertilidad.
MX2019014714A (es) Anticuerpos anti-trkb.
MX2019003755A (es) Regimen de dosificacion de avelumab para el tratamiento de cancer.